Weekly and every-3-week nab-paclitaxel followed by carboplatin as first-line therapy is effective in patients with advanced non-small cell lung cancer: final results of a phase II study
JOURNAL OF THORACIC ONCOLOGY（2009）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要